Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
AI
20/20 Biolabs, Inc. Common Stock
AIDX
Volume
186.84K
Next Earnings
November 13th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
AI
AIDX
AI
20/20 Biolabs, Inc. Common Stock
AIDX
News
·
20/20 BioLabs Reschedules Investor Webinar to 2:00 p.m. Eastern Time on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity
Mkt Cap
$3.5M
Volume
186.84K
Next Earnings
November 13th
Chart
Financials
Earnings
News
About
Insider
Filings
20/20 BioLabs Reschedules Investor Webinar to 2:00 p.m. Eastern Time on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity
20/20 BioLabs announced a rescheduled investor webinar for September 2, 2026 at 2:00 p.m. ET to discuss Q2 2026 results featuring record OneTest™ revenue of $0.7 million (47.1% YoY increase), gross margin expansion to 41.7%, and commercial expansion across multiple channels including firefighter cancer screening programs.
GlobeNewswire Inc. · Aug 28, 2026
20/20 BioLabs Announces Monthly Investor Webinar Series to be Held on the First Wednesday of Each Month
20/20 BioLabs (Nasdaq: AIDX) announced the launch of a recurring monthly investor webinar series starting July 1, 2026, held on the first Wednesday of each month at 12:00 p.m. ET. The initiative aims to increase transparency, strengthen shareholder communication, and provide direct access to management regarding the company's AI-powered blood tests for early cancer detection and chronic disease prevention.
GlobeNewswire Inc. · Jun 22, 2026
20/20 BioLabs Reports Full Year 2025 Financial Results and Recent Operational Progress
20/20 BioLabs (Nasdaq: AIDX) reported FY 2025 revenue of $2.0 million, up 17% year-over-year, with gross profit increasing 68% and gross margin expanding 900 basis points to 29.6%. The company achieved a 33% improvement in net loss to $3.7 million and reduced operating expenses by 35%. Recent highlights include a $5.0 million funding round, Nasdaq listing, $520,000 in Maryland state funding for firefighter cancer screenings, and launch of OneTest for Longevity. Management expects 2026 to be a breakout year driven by strong demand across firefighting, veterans, and occupational health markets.
GlobeNewswire Inc. · Mar 31, 2026
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
AI
AIDX
20/20 Biolabs, Inc. Common Stock
Buy
Sell
Market
Limit
Soon
AIDX
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any AIDX yet.
Related Tickers
Earnings